More than two dozen Democrats introduce bill to extend CMS drug price negotiations farther
Sens. Amy Klobuchar (D-MN), Peter Welch (D-VT), Dick Durbin (D-IL), Elizabeth Warren (D-MA) and 21 other Democrat colleagues introduced legislation yesterday that would shift the goal posts on when the Centers for Medicare and Medicaid Services can begin negotiations.
The already-established government negotiations beginning at 13 years for biologics and nine years for small molecule drugs would fall to just five years post-FDA approval under the bill, rapidly increasing the overall amount by which Medicare can save and rapidly increasing the riskiness of biopharma companies’ profits.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
